Study of advanced treatment in a patients with head & neck cancer patients as well as Breast cancer patients in advanceds stage
Not Applicable
- Conditions
- Health Condition 1: null- patients with extensive disease or unsalvageable recurrence where the options of surgery, radiation and conventional chemotherapy are exhausted, unsuitable or are refused by the patient
- Registration Number
- CTRI/2018/05/014018
- Lead Sponsor
- Tata memorial hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1 Patients of either gender aged > 18yrs
2 Head and neck cancer and breast patients with advanced skin involvement not suitable for conventional therapeutic treatments
3 Head and neck and breast cancer patients having recurrent disease where options of surgery, radiation and chemotherapy are exhausted and cannot be used
4 Patient refusing conventional modalities of treatment
5 Patients willing to consent for electrochemotherapy
Exclusion Criteria
1 Patients with deranged renal functions
2 Patients with severe systemic disease
3 Patients with severe co-morbidity medically unfit to undergo procedure
4 Patients allergic to bleomycin/ cisplatin
5 Patients not willing to consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the response rates to electrochemotherapy for head and neck and breast cancer patients in a palliative settingTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method quality of lifeTimepoint: not applicable